BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9002969)

  • 1. The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis.
    Conway EM; Pollefeyt S; Collen D; Steiner-Mosonyi M
    Blood; 1997 Jan; 89(2):652-61. PubMed ID: 9002969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain.
    Teasdale MS; Bird CH; Bird P
    Immunol Cell Biol; 1994 Dec; 72(6):480-8. PubMed ID: 7698819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombomodulin lacking the cytoplasmic domain efficiently internalizes thrombin via nonclathrin-coated, pit-mediated endocytosis.
    Conway EM; Nowakowski B; Steiner-Mosonyi M
    J Cell Physiol; 1994 Feb; 158(2):285-98. PubMed ID: 8106566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, activity, and preliminary structure of the fourth EGF-like domain of thrombomodulin.
    Meininger DP; Hunter MJ; Komives EA
    Protein Sci; 1995 Sep; 4(9):1683-95. PubMed ID: 8528067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of monoclonal antibodies to thrombomodulin.
    Tsuneyoshi N; Fukudome K; Higuchi K; Kimoto M
    Hybridoma (Larchmt); 2005 Aug; 24(4):189-96. PubMed ID: 16120024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways.
    Conway EM; Van de Wouwer M; Pollefeyt S; Jurk K; Van Aken H; De Vriese A; Weitz JI; Weiler H; Hellings PW; Schaeffer P; Herbert JM; Collen D; Theilmeier G
    J Exp Med; 2002 Sep; 196(5):565-77. PubMed ID: 12208873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis.
    Van de Wouwer M; Plaisance S; De Vriese A; Waelkens E; Collen D; Persson J; Daha MR; Conway EM
    J Thromb Haemost; 2006 Aug; 4(8):1813-24. PubMed ID: 16879225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of the fragment of thrombomodulin containing the fourth and fifth epidermal growth factor-like domains correlate with function.
    Prieto JH; Sampoli Benitez BA; Melacini G; Johnson DA; Wood MJ; Komives EA
    Biochemistry; 2005 Feb; 44(4):1225-33. PubMed ID: 15667216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain.
    Huang HC; Shi GY; Jiang SJ; Shi CS; Wu CM; Yang HY; Wu HL
    J Biol Chem; 2003 Nov; 278(47):46750-9. PubMed ID: 12951323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.
    Kokame K; Zheng X; Sadler JE
    J Biol Chem; 1998 May; 273(20):12135-9. PubMed ID: 9575159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles played by the D2 and D3 domains of recombinant human thrombomodulin in its function.
    Honda G; Masaki C; Zushi M; Tsuruta K; Sata M
    J Biochem; 1995 Nov; 118(5):1030-6. PubMed ID: 8749323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin structure and function.
    Sadler JE
    Thromb Haemost; 1997 Jul; 78(1):392-5. PubMed ID: 9198185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombomodulin: a multifunctional receptor modulating the endothelial quiescence.
    Giri H; Biswas I; Rezaie AR
    J Thromb Haemost; 2024 Apr; 22(4):905-914. PubMed ID: 38266676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains.
    Nawa K; Ono M; Fujiwara H; Sugiyama N; Uchiyama T; Marumoto Y
    Biochim Biophys Acta; 1994 Apr; 1205(2):162-70. PubMed ID: 7512385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.
    Zhang Y; Weiler-Guettler H; Chen J; Wilhelm O; Deng Y; Qiu F; Nakagawa K; Klevesath M; Wilhelm S; Böhrer H; Nakagawa M; Graeff H; Martin E; Stern DM; Rosenberg RD; Ziegler R; Nawroth PP
    J Clin Invest; 1998 Apr; 101(7):1301-9. PubMed ID: 9525972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thrombomodulin lectin-like domain in inflammation.
    Li YH; Kuo CH; Shi GY; Wu HL
    J Biomed Sci; 2012 Mar; 19(1):34. PubMed ID: 22449172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a thrombin-binding region in the sixth epidermal growth factor-like repeat of human thrombomodulin.
    Tolkatchev D; Ng A; Zhu B; Ni F
    Biochemistry; 2000 Aug; 39(34):10365-72. PubMed ID: 10956026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain.
    Horowitz NA; Blevins EA; Miller WM; Perry AR; Talmage KE; Mullins ES; Flick MJ; Queiroz KC; Shi K; Spek CA; Conway EM; Monia BP; Weiler H; Degen JL; Palumbo JS
    Blood; 2011 Sep; 118(10):2889-95. PubMed ID: 21788337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity.
    Tsiang M; Lentz SR; Sadler JE
    J Biol Chem; 1992 Mar; 267(9):6164-70. PubMed ID: 1313430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity.
    Nagashima M; Lundh E; Leonard JC; Morser J; Parkinson JF
    J Biol Chem; 1993 Feb; 268(4):2888-92. PubMed ID: 8381415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.